Authors
Latest:
Top Executives Vow to Improve Health Disparities among Patients with Multiple MyelomaOncology nurses are often the main point of contact for newly diagnosed patients with cancer. We have the opportunity to ensure that each person starts their journey with equality and equity on their side.
Latest:
Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.
Latest:
Chemotherapy Plus Endocrine Therapy Increases Cognitive Impairment in Breast CancerPatients with breast cancer may be at risk for more intense cognitive impairment following treatment with chemotherapy plus endocrine therapy.
Latest:
Injection Time Can Encourage Bonding During Myeloma CareThe extended injection time for subcutaneous daratumumab in those with myeloma can serve as an opportunity for oncology nurses to check in with patients.
Latest:
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing RadiationHilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Latest:
Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival TimesPatients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.
Latest:
Best Practices in Managing Talquetamab-Associated AEs in MyelomaA nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma.
Latest:
Germline Testing: When to Trust a Patient’s GutNurse practitioners should listen to patients’ concerns and be ready with questions when it comes to germline testing, according to an expert.
Latest:
Karmanos nurse wins MDONS Outstanding Oncology Nurse of the Year AwardAgnes Pilecki, BSN, RN, a nurse on Barbara Ann Karmanos Cancer Institute’s bone marrow transplant unit, has been named the Metro Detroit Oncology Nursing Society’s (MDONS) Outstanding Oncology Nurse of the Year.
Latest:
Approach Health Disparities From All AnglesApril is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.
Latest:
Reanne Booker on Factors to Consider When Discussing Palliative RadiationReanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.
Latest:
Care Management Tools Can Mitigate Clinician BurnoutAlthough technology alone can’t solve clinician burnout, it can provide the means for organizations to provide better care while increasing efficiency and alleviating stress.
Latest:
Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian CancerPaula Anastasia, RN, MN, AOCN, highlights circumstances in which patients may not be eligible to receive benefit with a PARP inhibitor.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Real-World Data Support Enfortumab Vedotin for Urothelial Carcinoma TreatmentReal-world data demonstrate significant outcome improvements with enfortumab vedotin in patients with unresectable or metastatic urothelial carcinoma.
Latest:
Optimizing Multidisciplinary Care for ESR1-Mutated Breast Cancer: Strategies and Future DirectionsPanelists discuss strategies for medication adherence and patient education, emphasizing the importance of proactive communication and support from the entire health care team.
Latest:
Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic TestsCheryl VerStrate, DNP, AGPCNP-BC, OCN, discusses why nurses should be prepared to discuss direct-to-consumer genomic testing with their patients.
Latest:
Pacritinib SVR Tied to OS Benefit in Thrombocytopenic MyelofibrosisSVR10 at week 12 with pacritinib was linked to longer overall survival in patients with myelofibrosis and thrombocytopenia.
Latest:
Aliènne Salleroli on Starting the DEI Conversation in Oncology NursingAliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.
Latest:
Oncology Rapid Access Clinics: APPs Improve Outcomes for Acutely Ill PatientsOncology rapid-access clinics should be essential to patient care standards across the oncology continuum.
Latest:
Michelle Mollica on Individualizing Care Plans for Cancer SurvivorsMichelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.
Latest:
Bring A Nuanced Approach to Venous Thromboembolism ManagementUnderstanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Latest:
FDA Approves Perioperative Pembrolizumab in Head and Neck SCCThe FDA approved a perioperative pembrolizumab regimen in head and neck squamous cell carcinoma, marking the first approval in this cancer type in 6 years.
Latest:
Practicing ‘Top of License’ Can Enhance Patient Care, CollaborationPracticing at top of licensure can create opportunities for oncology APPs to engage with patients and other providers in new ways.
Latest:
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast CancerKara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Elizabeth Aronson Walks Through the Data Supporting Elranatamab Approval in Multiple MyelomaElizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MagnetisMM-3 trial assessing elranatamab in multiple myeloma.
Latest:
Peripheral Neuropathy Treatable With Teliso-V in C–Met-High NSCLCToxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to Jonathan Goldman, MD.
Latest:
Five Researchers Awarded Pilot Project FundingEvery year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty.
